Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model

S. Martins, M. de Perrot, Y. Imai, Masaomi Yamane, S. M. Quadri, L. Segall, A. Dutly, S. Sakiyama, A. Chaparro, B. L. Davidson, T. K. Waddell, M. Liu, S. Keshavjee

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Interleukin-10 (IL-10) gene transfection of donor lungs prior to transplantation is an attractive strategy to reduce ischemia-reperfusion induced lung injury. However, experimental data with gene therapy in large animal models of lung transplantation are generally lacking. We have developed a simple clinically applicable technique for adenoviral-mediated gene delivery of human IL-10 to the lung of large animals that provides homogenous gene expression after 12-24 h of transfection. Using this technique of gene delivery, we have studied the dynamics of adenoviral gene delivery to the lung in the setting of lung transplantation. Although there is a persistent inflammatory response to the adenoviral vector, we achieved significant expression of human IL-10 in lung tissue before lung retrieval to obviate the deleterious impact of the adenoviral vector on the donor lung. The administration of adenoviral-mediated human IL-10 to the donor lung reduced ischemia-reperfusion injury and improved graft function after lung transplantation in this pig lung transplantation model. Transfection of adenoviral-mediated human IL-10 to the donor lung prevented the release of inflammatory cytokines such as IL-6 in lung tissue and plasma. We have demonstrated that IL-10 gene therapy has significant potential to prevent or treat the inflammatory response associated with ischemia-reperfusion injury in lung transplantation. In the future, IL-10 gene therapy could also be used for immunomodulation or tolerance induction.

Original languageEnglish
Pages (from-to)1786-1796
Number of pages11
JournalGene Therapy
Volume11
Issue number24
DOIs
Publication statusPublished - Dec 2004
Externally publishedYes

Fingerprint

Interleukin-10
Swine
Transplants
Lung Transplantation
Lung
Genes
Genetic Therapy
Transfection
Reperfusion Injury
Immunomodulation
Lung Injury
Reperfusion
Interleukin-6
Ischemia
Animal Models
Transplantation
Cytokines
Gene Expression

Keywords

  • Adenovirus
  • Cytokines
  • Interleukin-10
  • Ischemia-reperfusion injury
  • Lung transplantation

ASJC Scopus subject areas

  • Genetics

Cite this

Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. / Martins, S.; de Perrot, M.; Imai, Y.; Yamane, Masaomi; Quadri, S. M.; Segall, L.; Dutly, A.; Sakiyama, S.; Chaparro, A.; Davidson, B. L.; Waddell, T. K.; Liu, M.; Keshavjee, S.

In: Gene Therapy, Vol. 11, No. 24, 12.2004, p. 1786-1796.

Research output: Contribution to journalArticle

Martins, S, de Perrot, M, Imai, Y, Yamane, M, Quadri, SM, Segall, L, Dutly, A, Sakiyama, S, Chaparro, A, Davidson, BL, Waddell, TK, Liu, M & Keshavjee, S 2004, 'Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model', Gene Therapy, vol. 11, no. 24, pp. 1786-1796. https://doi.org/10.1038/sj.gt.3302357
Martins, S. ; de Perrot, M. ; Imai, Y. ; Yamane, Masaomi ; Quadri, S. M. ; Segall, L. ; Dutly, A. ; Sakiyama, S. ; Chaparro, A. ; Davidson, B. L. ; Waddell, T. K. ; Liu, M. ; Keshavjee, S. / Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. In: Gene Therapy. 2004 ; Vol. 11, No. 24. pp. 1786-1796.
@article{877dcd03355d4adf83b4e446400784fb,
title = "Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model",
abstract = "Interleukin-10 (IL-10) gene transfection of donor lungs prior to transplantation is an attractive strategy to reduce ischemia-reperfusion induced lung injury. However, experimental data with gene therapy in large animal models of lung transplantation are generally lacking. We have developed a simple clinically applicable technique for adenoviral-mediated gene delivery of human IL-10 to the lung of large animals that provides homogenous gene expression after 12-24 h of transfection. Using this technique of gene delivery, we have studied the dynamics of adenoviral gene delivery to the lung in the setting of lung transplantation. Although there is a persistent inflammatory response to the adenoviral vector, we achieved significant expression of human IL-10 in lung tissue before lung retrieval to obviate the deleterious impact of the adenoviral vector on the donor lung. The administration of adenoviral-mediated human IL-10 to the donor lung reduced ischemia-reperfusion injury and improved graft function after lung transplantation in this pig lung transplantation model. Transfection of adenoviral-mediated human IL-10 to the donor lung prevented the release of inflammatory cytokines such as IL-6 in lung tissue and plasma. We have demonstrated that IL-10 gene therapy has significant potential to prevent or treat the inflammatory response associated with ischemia-reperfusion injury in lung transplantation. In the future, IL-10 gene therapy could also be used for immunomodulation or tolerance induction.",
keywords = "Adenovirus, Cytokines, Interleukin-10, Ischemia-reperfusion injury, Lung transplantation",
author = "S. Martins and {de Perrot}, M. and Y. Imai and Masaomi Yamane and Quadri, {S. M.} and L. Segall and A. Dutly and S. Sakiyama and A. Chaparro and Davidson, {B. L.} and Waddell, {T. K.} and M. Liu and S. Keshavjee",
year = "2004",
month = "12",
doi = "10.1038/sj.gt.3302357",
language = "English",
volume = "11",
pages = "1786--1796",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "24",

}

TY - JOUR

T1 - Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model

AU - Martins, S.

AU - de Perrot, M.

AU - Imai, Y.

AU - Yamane, Masaomi

AU - Quadri, S. M.

AU - Segall, L.

AU - Dutly, A.

AU - Sakiyama, S.

AU - Chaparro, A.

AU - Davidson, B. L.

AU - Waddell, T. K.

AU - Liu, M.

AU - Keshavjee, S.

PY - 2004/12

Y1 - 2004/12

N2 - Interleukin-10 (IL-10) gene transfection of donor lungs prior to transplantation is an attractive strategy to reduce ischemia-reperfusion induced lung injury. However, experimental data with gene therapy in large animal models of lung transplantation are generally lacking. We have developed a simple clinically applicable technique for adenoviral-mediated gene delivery of human IL-10 to the lung of large animals that provides homogenous gene expression after 12-24 h of transfection. Using this technique of gene delivery, we have studied the dynamics of adenoviral gene delivery to the lung in the setting of lung transplantation. Although there is a persistent inflammatory response to the adenoviral vector, we achieved significant expression of human IL-10 in lung tissue before lung retrieval to obviate the deleterious impact of the adenoviral vector on the donor lung. The administration of adenoviral-mediated human IL-10 to the donor lung reduced ischemia-reperfusion injury and improved graft function after lung transplantation in this pig lung transplantation model. Transfection of adenoviral-mediated human IL-10 to the donor lung prevented the release of inflammatory cytokines such as IL-6 in lung tissue and plasma. We have demonstrated that IL-10 gene therapy has significant potential to prevent or treat the inflammatory response associated with ischemia-reperfusion injury in lung transplantation. In the future, IL-10 gene therapy could also be used for immunomodulation or tolerance induction.

AB - Interleukin-10 (IL-10) gene transfection of donor lungs prior to transplantation is an attractive strategy to reduce ischemia-reperfusion induced lung injury. However, experimental data with gene therapy in large animal models of lung transplantation are generally lacking. We have developed a simple clinically applicable technique for adenoviral-mediated gene delivery of human IL-10 to the lung of large animals that provides homogenous gene expression after 12-24 h of transfection. Using this technique of gene delivery, we have studied the dynamics of adenoviral gene delivery to the lung in the setting of lung transplantation. Although there is a persistent inflammatory response to the adenoviral vector, we achieved significant expression of human IL-10 in lung tissue before lung retrieval to obviate the deleterious impact of the adenoviral vector on the donor lung. The administration of adenoviral-mediated human IL-10 to the donor lung reduced ischemia-reperfusion injury and improved graft function after lung transplantation in this pig lung transplantation model. Transfection of adenoviral-mediated human IL-10 to the donor lung prevented the release of inflammatory cytokines such as IL-6 in lung tissue and plasma. We have demonstrated that IL-10 gene therapy has significant potential to prevent or treat the inflammatory response associated with ischemia-reperfusion injury in lung transplantation. In the future, IL-10 gene therapy could also be used for immunomodulation or tolerance induction.

KW - Adenovirus

KW - Cytokines

KW - Interleukin-10

KW - Ischemia-reperfusion injury

KW - Lung transplantation

UR - http://www.scopus.com/inward/record.url?scp=19944382763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944382763&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302357

DO - 10.1038/sj.gt.3302357

M3 - Article

C2 - 15470481

AN - SCOPUS:19944382763

VL - 11

SP - 1786

EP - 1796

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 24

ER -